Back

The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation - Detection, treatment, outcomes Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor John Camm

City St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Premature atrial contractions are associated with atrial fibrillation, brain ischemia, and mortality: a systematic review and meta-analysis
Doctor J. Himmelreich (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Real-world observational data confirm the efficacy of atrial antitachycardia pacing in terminating slow and regular atrial tachyarrhythmias in patients wearing implantable cardiac electronic devices.
Professor G. Boriani (Modena, IT)
Abstract
Presentation thumbnail
Value of interatrial block for the prediction of silent ischemic brain lesions
Doctor G. Cinier (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Prevalence of silent vascular brain lesions among patients with atrial fibrillation and no known history of stroke
Doctor S. Blum (Basel, CH)
Abstract
Presentation thumbnail
Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide - preliminary results from the strokestop 2 study
Doctor K. Kemp Gudmundsdottir (Reykjavik, IS)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation - Detection, treatment, outcomes

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources